Angiodynamics (ANGO) Other Accumulated Expenses (2012 - 2026)

Angiodynamics (ANGO) has 13 years of Other Accumulated Expenses data on file, last reported at $4.7 million in Q1 2026.

• For the quarter ending Q1 2026, Other Accumulated Expenses fell 19.09% year-over-year to $4.7 million; the trailing twelve-month figure through Feb 2026 stood at $4.7 million (down 19.09% YoY), and the FY2025 full-year result was $7.4 million, down 2.51% from the prior year.
• Other Accumulated Expenses for Q1 2026 stood at $4.7 million, down from $6.7 million in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $10.3 million in Q1 2024 and bottomed at $1.8 million in Q4 2023.
• The 5-year median for Other Accumulated Expenses is $4.7 million (2026), against an average of $5.0 million.
• The widest annual swing landed in 2024, when Other Accumulated Expenses surged 408.79%; it then slumped 43.88% in 2025.
• A 5-year view of Other Accumulated Expenses shows it stood at $2.6 million in 2022, then slumped by 31.83% to $1.8 million in 2023, then soared by 408.79% to $9.0 million in 2024, then retreated by 25.08% to $6.7 million in 2025, then plunged by 30.68% to $4.7 million in 2026.
• The last three Other Accumulated Expenses figures came in at $4.7 million (Q1 2026), $6.7 million (Q4 2025), and $8.7 million (Q3 2025), per Business Quant data.

Peer Comparison